Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-26 @ 2:13 AM
Study NCT ID:
NCT01111305
Status:
COMPLETED
Last Update Posted:
2022-01-27
First Post:
2010-04-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
10-I-0101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None